Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Just under €212m was spent on Ozempic and Saxenda under the medical card, Drugs Payment Scheme and Long-Term Illness schemes in two years and eight months ...

Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) ...

Novo Nordisk brought in Justin Long and John Hodgman, who had been in the Apple "Get A Mac" ads from 20 years ago, to star in ...

The moment I administered my first weight-loss jab, I felt an overwhelming sense of relief. I'd been dieting since I was 15.

Company Further Examining the Pursuit of the World's First Oral Liraglutide Product KELOWNA, BC / ACCESS Newswire / February 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexari ...

Up to €70,000 spent on inmates wanting to slim down ...

Prisoners are being prescribed weight-loss drugs behind bars and the amount the Irish Prison Service (IPS) is spending on Ozempic is on the rise.

BRITS have been warned not to use four brands of skin cleansing wipes “under any circumstances”. The products have been ...

DOCTORS have issued a warning in relation to weight-loss jabs after a man in Dublin went blind in one eye after using the ...

Sales growth was driven by both US Operations and International Operations. The volume growth of the global branded GLP-1 ...

Use of SGLT2 inhibitors was associated with lower 5-year risk for chronic kidney disease and AKI compared with GLP-1 receptor ...